Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-24-114823
Filing Date
2024-11-06
Accepted
2024-11-06 16:36:24
Documents
1
Group Members
BAYER AKTIENGESELLSCHAFT

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm2427363d3_sc13ga.htm SC 13G/A 55952
  Complete submission text file 0001104659-24-114823.txt   57436
Mailing Address 321 HARRISON AVENUE BOSTON MA 02118
Business Address 321 HARRISON AVENUE BOSTON MA 02118 (617) 221-9059
Pyxis Oncology, Inc. (Subject) CIK: 0001782223 (see all company filings)

EIN.: 831160910 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92951 | Film No.: 241431643
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address ENERGIEWEG 1 MIJDRECHT P7 3641
Business Address ENERGIEWEG 1 MIJDRECHT P7 3641 00 31 297 280 666
Bayer World Investments B.V. (Filed by) CIK: 0001820027 (see all company filings)

EIN.: 000000000
Type: SC 13G/A